LLY vs VTRS
By Alex · Tickerpine
Eli Lilly and Company vs Viatris Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | LLY | VTRS |
|---|---|---|
| Price | $1,208.12 | $16.33 |
| Market cap | $1.08T | $19.02B |
| P/E ratio | 42.9 | — |
| ROE | 107.46% | -1.96% |
| Profit margin | 34.99% | -2.04% |
| Revenue growth | 55.50% | 8.10% |
| Dividend yield | 0.57% | 2.94% |
| Beta | 0.52 | 0.90 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
LLY vs VTRS in plain English
- LLY is the bigger company — about 56.7× the market cap of VTRS.
- LLY earns a higher return on equity (107% vs -2%).
- LLY is growing revenue faster (56% vs 8%).
- VTRS has the higher dividend yield (2.94% vs 0.57%).
How would $1,000 have done in each?
LLY return calculator
See what $1,000 in Eli Lilly and Company would be worth today.
VTRS return calculator
See what $1,000 in Viatris Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.